Supporting Canada's back to normal: Roche Diagnostics Canada introduces the new SARS-CoV-2 Rapid Antigen Test Nasal approved under Health Canada's Interim Order

LAVAL, QC, June 30, 2021 /CNW Telbec/ - A few weeks after announcing the availability of its Elecsys® Anti-SARS-CoV-2-S (spike protein) antibody test, Roche Diagnostics, a division of Hoffmann-La Roche Limited, is pleased to announce that its SARS-CoV-2 Rapid Antigen Test Nasal, commercialized under a Global partnership with SD Biosensor Inc., has received approval under Health Canada's Interim Order, increasing Roche's contribution to the fight against the pandemic.

NewsGuest UserJune 30, 2021Roche, COVID-19, Antigen detection test, Approval

SemaThera Enters into a Research Collaboration and Exclusive License Agreement with Roche

MONTREAL--(BUSINESS WIRE)--SemaThera Inc. today announced the signing of a multi-year research collaboration and licensing agreement with Roche. The partnership will focus on developing SemaThera’s promising new class of biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases.

NewsGuest UserMarch 22, 2021SemaThera, Roche, Collaboration